Surveillance data and model estimates for weekly incidence of cases.

About this item

Title

Surveillance data and model estimates for weekly incidence of cases.

Content partner

FigShare

Collection

FigShare

Description

For each country, graphs show observed case incidence from surveillance data (black points), the 95% credibility region on incidence from the country-specific fits (grey region) and predicted incidence for the posterior median set of parameters obtained from the global fits (dashed lines) for model variants M1 (blue), M2 (green) and M3 (red). Weekly incidence from the models is plotted in all cases, with lines being drawn between weeks for visual clarity. Depending on the country, observed ca...

Read more

Format

Image

Date created

01 Sep, 2011

Creator

Lulla Opatowski / Christophe Fraser / Jamie Griffin / Eric de Silva / Maria D. Van Kerkhove / Emily J. Lyons / Simon Cauchemez / Neil M. Ferguson

URL

https://figshare.com/articles/figure/_Surveillance_data_and_model_estimates_for_weekly_incidence_...

Related subjects

estimates / incidence / Biotechnology / Infectious Diseases

What is the copyright status of this item?

Creative Commons

This item appears to be licensed under a Creative Commons Attribution (BY) CC International license.

More Information

FigShare has this to say about the rights status of this item:

http://figshare.com/licensing

You can learn more about the rights status of this item at: http://creativecommons.org/licenses/by/4.0

What can I do with this item?

You must always check with FigShare to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it

This item is suitable for copying and sharing with others, without further permission.

Modify it

This item is suitable for modifying, remixing and building upon, without further permission.

Use it commercially

This item is suitable for commercial use, without further permission.